The first Chinese national standards for SARS-CoV-2 neutralizing antibody

In order to meet the domestic urgent needs of evaluating the immunogenicity of vaccines and the potency testing of therapeutic antibody products against coronavirus disease 2019 (COVID-19), the first Chinese national standards for SARS-CoV-2 neutralizing antibody were established. The potency and st...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Lidong, Yu, Yuanling, Wu, Xiaohong, Nie, Jianhui, Zhang, Jun, Wang, Zejun, Li, Na, Shi, Rui, Zhao, Hui, Chen, Hongbo, Luo, Chunxia, Hu, Yaling, Wang, Youchun, Huang, Weijin, Xu, Miao, Hou, Jifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133612/
https://www.ncbi.nlm.nih.gov/pubmed/34059373
http://dx.doi.org/10.1016/j.vaccine.2021.05.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133612/
https://www.ncbi.nlm.nih.gov/pubmed/34059373
http://dx.doi.org/10.1016/j.vaccine.2021.05.047

Ejemplares similares